info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)

Getinge Introduced Volista VisioNIR, Projected To Disrupt The Surgical Lighting Industry

By Indu Tyagi Ketan , 17 November, 2022

Getinge introduced Volista VisioNIR, a revolutionary surgical light solution, in October 2021. The product was aimed to enable surgical professionals to continue using the operating light during open procedures when employing NIR fluorescence imaging equipment. To find structures that need to be removed, such as sentinel lymph nodes, cancerous cells, and luminal calcifications, and to avoid other systems that might result in acute or long-term morbidity, such as nerves, blood vessels, ducts, lymphatics, and healthy glands, NIR (near-infrared) fluorescence imaging was developed.

When using fluorescence-guided surgery, the new Volista VisioNIR function aids in guiding surgeons and securing their actions with more excellent hand-eye synchronization. No longer is it necessary to alternate between on and off lights. Lights remaining on during the entire treatment ensures an unbroken workflow where staff can devote all their attention to the patient, saving time and resources.

It is anticipated that the product has the potential to upend the surgical light market. The use of adequate lighting is essential for accurate and efficient surgical performance for the best achievable patient outcome. The surgeon's headlight is the gold standard for intense, focused lighting. Still, it has several drawbacks, such as physical discomfort, encouragement of poor ergonomic posture, a lack of cleanliness, and a role in physician distraction during treatment. Headlights’ impact on surgery—a physically taxing activity already—may be the most harmful. An incorrect ergonomic position can eventually cause the surgeon to sustain a significant physical injury and experience chronic pain.

Additionally, the market has witnessed similar product introductions and innovations intended for similar concerns.  For instance, Josh Mezrich, a transplant surgeon at the University of Wisconsin, created the MezLight in response to his and his colleagues' experiences with the need for more excellent lighting in the operating room.

GBD Disease Catagories

Categories.png

Latest News

2025.png
Honda and Renesas Collaborate for Next-Gen Software-Defined Vehicles in 2025

In January 2025, Honda Motor Co., Ltd. and Renesas Electronics Corporation declared a strategic collaboration to create a high-performance system on a chip (SoC) designed for Software Defined Vehicles (SDVs). This cooperation is intended to bolster…

Read More

2025.png
NVIDIA's Mega Omniverse Master Plan: Revolutionizing Robotics and AI by 2025

 In 2025, NVIDIA is set to transform AI and robotics with its Mega Omniverse Blueprint, a framework for designing, simulating, and optimizing robot fleets within the digital twins of industrial environments. This new initiative combines NVIDIA's…

Read More

Diseases.png
How Vaccines Helped Eradicate Deadly Diseases – A 2025 Breakthrough

Public health has benefited dramatically from vaccinations, which have helped completely eradicate or significantly lower the frequency of lethal illnesses. Vaccines will still be among the most potent weapons available in 2025 to stop global…

Read More

2025.png
Oil Prices Crash in 2025: Biggest Weekly Drop Amid Tariffs & Oversupply

Oil prices stay on track as United States (U.S.) sanctions on Canada and Mexico keep diverting the market and stable supply levels support a significant weekly decline in 2025. Reuters said this is the biggest weekly decline since October…

Read More

2025.png
Quadric and Denso Team Up to Progress Automotive AI Semiconductors for 2025

The automotive industry will benefit significantly from strategic partnerships in artificial intelligence (AI) and its use in cars. AI integration into automobiles is projected to improve considerably in the year 2025 due to the formation of various…

Read More

Author Pic
Indu Tyagi Ketan

Chief Strategy Officer